Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events

被引：0
|
作者：
Olga Sobolev
Elisa Binda
Sean O'Farrell
Anna Lorenc
Joel Pradines
Yongqing Huang
Jay Duffner
Reiner Schulz
John Cason
Maria Zambon
Michael H Malim
Mark Peakman
Andrew Cope
Ishan Capila
Ganesh V Kaundinya
Adrian C Hayday
机构：
[1] King's College London,Peter Gorer Department of Immunobiology
[2] ImmunoSurveillance Laboratory,Division of Rheumatology
[3] Francis Crick Institute,Department of Genetics
[4] Lincoln's Inn Laboratories,Department of Infectious Diseases
[5] Biomedical Research Centre at Guy's and St Thomas' Hospital and King's College London,Academic Department of Rheumatology
[6] Rheumatology and Translational Immunology Research Laboratories (LaRIT),undefined
[7] IRCCS Policlinico San Matteo/University of Pavia,undefined
[8] Momenta Pharmaceuticals,undefined
[9] King's College London,undefined
[10] King's College London,undefined
[11] Public Health England,undefined
[12] Colindale,undefined
[13] Centre for Molecular and Cell Biology of Inflammation,undefined
[14] King's College London,undefined
来源：
Nature Immunology | 2016年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Vaccination offers protection against infectious diseases, yet pre-existing criteria that predict vaccine efficacy or adverse events remain unknown. Hayday and colleagues identify cellular and molecular signatures in humans immunized with adjuvanted swine flu vaccine.
引用
收藏
页码：204 / 213
页数：9
相关论文
共 50 条
  • [1] Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events
    Sobolev, Olga
    Binda, Elisa
    O'Farrell, Sean
    Lorenc, Anna
    Pradines, Joel
    Huang, Yongqing
    Duffner, Jay
    Schulz, Reiner
    Cason, John
    Zambon, Maria
    Malim, Michael H.
    Peakman, Mark
    Cope, Andrew
    Capila, Ishan
    Kaundinya, Ganesh V.
    Hayday, Adrian C.
    NATURE IMMUNOLOGY, 2016, 17 (02) : 204 - 213
  • [2] Correction: Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events
    Olga Sobolev
    Elisa Binda
    Sean O'Farrell
    Anna Lorenc
    Joel Pradines
    Yongqing Huang
    Jay Duffner
    Reiner Schulz
    John Cason
    Maria Zambon
    Michael H Malim
    Mark Peakman
    Andrew Cope
    Ishan Capila
    Ganesh V Kaundinya
    Adrian C Hayday
    Nature Immunology, 2016, 17 : 740 - 740
  • [3] Correction: Corrigendum: Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events
    Olga Sobolev
    Elisa Binda
    Sean O'Farrell
    Anna Lorenc
    Joel Pradines
    Yongqing Huang
    Jay Duffner
    Reiner Schulz
    John Cason
    Maria Zambon
    Michael H Malim
    Mark Peakman
    Andrew Cope
    Ishan Capila
    Ganesh V Kaundinya
    Adrian C Hayday
    Nature Immunology, 2016, 17 : 469 - 469
  • [4] Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events (vol 17, pg 204, 2016)
    Sobolev, Olga
    Binda, Elisa
    O'Farrell, Sean
    Lorenc, Anna
    Pradines, Joel
    Huang, Yongqing
    Duffner, Jay
    Schulz, Reiner
    Cason, John
    Zambon, Maria
    Malim, Michael H.
    Peakman, Mark
    Cope, Andrew
    Capila, Ishan
    Kaundinya, Ganesh V.
    Hayday, Adrian C.
    NATURE IMMUNOLOGY, 2016, 17 (06) : 740 - 740
  • [5] Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events (vol 17, pg 204, 2016)
    Sobolev, Olga
    Binda, Elisa
    O'Farrell, Sean
    Lorenc, Anna
    Pradines, Joel
    Huang, Yongqing
    Duffner, Jay
    Schulz, Reiner
    Cason, John
    Zambon, Maria
    Malim, Michael H.
    Peakman, Mark
    Cope, Andrew
    Capila, Ishan
    Kaundinya, Ganesh V.
    Hayday, Adrian C.
    NATURE IMMUNOLOGY, 2016, 17 (04) : 469 - 469
  • [6] Risk of Fatal Adverse Events after H1N1 Influenza Vaccination
    Nakada, Haruka
    Narimatsu, Hiroto
    Tsubokura, Masaharu
    Murashige, Naoko
    Matsumura, Tomoko
    Kodama, Yuko
    Kishi, Yukiko
    Kami, Masahiro
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) : 1548 - 1549
  • [7] Monitoring Adverse Events of the Vaccination Campaign Against Influenza A (H1N1) in the Netherlands
    Eugène P. van Puijenbroek
    Kees van Grootheest
    Drug Safety, 2010, 33 : 1097 - 1108
  • [8] Monitoring Adverse Events of the Vaccination Campaign Against Influenza A (H1N1) in the Netherlands
    van Puijenbroek, Eugene P.
    Broos, Nancy
    van Grootheest, Kees
    DRUG SAFETY, 2010, 33 (12) : 1097 - 1108
  • [9] Active Monitoring of Adverse Events during an MF59®-Adjuvanted H5N1 Influenza Vaccination Campaign in Taiwan
    Huang, Wan-Ting
    Hsiao, Wen-I
    Chang, Chi-Hsi
    Peng, Mei-Cheng
    Chuang, Jen-Hsiang
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 364 - 364
  • [10] Telephone monitoring of adverse events during an MF59®-adjuvanted H5N1 influenza vaccination campaign in Taiwan
    Huang, Wan-Ting
    Chang, Chih-Hsi
    Peng, Mei-Chen
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (01) : 100 - 103
12345